Genenta Science
  • who we are
  • our companies
  • stories
  • investors
Select Page
← Press Coverage

Milano Finanza

La biotech italiana Genenta punta a 35 mln dollari con un’ipo al Nasdaq

10 November 2021
La biotech italiana Genenta punta a 35 mln dollari con un’ipo al Nasdaq Apri immagine a schermo intero ↗
CONTACT
NEWSROOM
© 2026 Genenta Science. All Rights Reserved - Terms and conditions - Privacy Policy - Whistleblowing - P.IVA 08738490963